Facial nerve palsies are a common and significant presentation specifically to ear, nose, and throat (ENT) surgeons but also in general medical practice. The facial nerve is a fundamental structure both for communication and emotion, and as such, functional impairment can lead to a significant deterioration in the quality of life.
A key element in the initial assessment of a patient presenting with facial weakness is distinguishing between a lower motor neuron (LMN) versus an upper motor neuron (UMN) palsy, as the likely causes and, therefore, treatment for these vary significantly. Applying anatomy to clinical history and examination, a clinician can identify the probable cause of facial nerve palsy and subsequently direct management appropriately.
Idiopathic/Bell Palsy (70%)
Most commonly, the cause for facial nerve palsy remains unknown and has the name ‘Bell palsy.' Bell palsy has an incidence of 10 to 40 per 100000. It is a diagnosis of exclusion.
It usually presents as a lower motor neuron lesion with total unilateral palsy. There is thought to be a viral prodromal period, and it can be recurrent in up to 10% of patients; however, the presence of a facial nerve palsy tends to present fully during the first 24 to 48 hours.  Damage to the nerve from compression within the bony canal can lead to edema and secondary pressure resulting in ischemia and reduced function. Recovery can take up to 1 year and is incomplete in as much as 13% of patients.
Trauma (10 to 23%)
Fractures involving the petrous part of the temporal bone and facial wounds transecting the branches of the facial nerve can cause facial nerve palsies. It takes an incredibly large force to fracture the temporal bone, and the clinician must look for signs such as hemotympanum, battles sign, and nystagmus. Temporal bone fractures usually occur unilaterally and are classified according to the plane of fracture along the petrous ridge (i.e., longitudinal vs. transverse.  Additionally, iatrogenic injury during otological, parotid, and acoustic neuroma surgery can result in traumatic damage to the facial nerve and stretch injury. Clinical history is vital in identifying the likely cause.
Neoplasia (2.2 to 5%)
A slowly progressing onset of facial palsy should raise the suspicion of malignancy and prompt a full and thorough head and neck examination. Malignancies resulting in facial nerve paralysis include (but are not exclusive to) parotid malignancies, facial and acoustic neuromas, meningioma, and arachnoid cysts. These will all present with varying degrees and manifestations of facial nerve palsy due to the relative location of the tumor.
Facial Nerve Palsy in Children
The causes of facial nerve palsy in children classify as either congenital or acquired. Acquired causes are the same as in adults as described above, and all of the above etiologies can occur in children.
Congenital causes include:
It is worth noting that surgical decompression of the facial nerve within the labyrinthine segment is not recommended for the pediatric population as research has failed to demonstrate beneficial outcomes, and there is a significant risk of sensorineural hearing loss with the procedure. However, nerve grafts and muscle transfer techniques may still be options for this cohort.
Bilateral Facial Nerve Palsy
Bilateral facial nerve paresis is an uncommon but essential branch of facial nerve palsy, occurring in between 0.3 to 2% of all facial nerve palsies. Bilateral palsy is important as it is much more likely to represent a systemic manifestation of the disease, with under 20% of cases being idiopathic. Lyme disease represents a significant portion of bilateral facial nerve palsies, accounting for around 35% of cases. Other important differential considerations include Guillain-Barre syndrome, diabetes, and sarcoidosis. Neurological causes of a bilateral facial nerve palsy include Parkinson disease, multiple sclerosis, and pseudobulbar/bulbar palsy.
While the majority of cases are found to be idiopathic, any clinician needs to rule out a cerebrovascular event or other serious underlying pathology. At present, no clear evidence exists to suggest facial nerve palsies are more likely in any gender or race, and all ages could be affected. However, it is a known fact that facial nerve palsies most commonly affect those between the ages of 15 to 45 years.
Within the spectrum of facial nerve palsies, the most common cause is Bell palsy, representing approximately 70% of all facial nerve paralysis. Trauma represents the next largest component of facial nerve palsies, contributing around 10 to 23% of cases. Viral infection resulting in a facial nerve palsy is responsible for between 4.5 to 7%, and finally, neoplasia constitutes between 2.2 to 5%.
The mechanism of paralysis of the facial nerve is dependent on the cause. Due to the facial nerve running through a narrow bony canal within the intratemporal course, any cause of inflammation or growth of the nerve will result in ischaemic changes through compression. The nerve is narrowest at the labyrinthine segment; therefore, compression is most likely to occur at this point. Additionally, any cause of skeletal abnormality or trauma may result in disruption of the relationship between the facial nerve and its bony canal, causing paralysis. Some iatrogenic causes of facial nerve palsy (such as acoustic neuroma surgery) occur due to secondary stretching forces as a result of the surgery.
A history of a patient with a viral prodromal period and facial nerve palsy may indicate Bell palsy or RHS. Asking the patient about the development of vesicular eruptions will help distinguish this further. A good otological history (e.g., otalgia, discharge, hearing loss, feeling of fullness in the ear, tinnitus, dizziness) will help to elicit a potential otitis externa/media. It may also assist in the diagnosis of an acoustic neuroma or cholesteatoma. A neurological history is relevant in the context of a UMN facial nerve palsy to help potentially elucidate the cause.
Testing facial movements will help distinguish between an upper (the forehead will be spared) and lower (entire facial movements are compromised) motor neuronal lesion. The degree of facial nerve paralysis is evaluated using the House-Brackman grading system.
Importantly, the difference between grades 3 and 4 is eye closure.
Additional tests used to assess the lesion of the facial nerve clinically are as follows:
Examine the ear externally to ensure no evidence of otitis externa, otitis media, chronic otitis media, or cholesteatoma. The presence of vesicles may indicate Ramsay-Hunt syndrome.
Examine the parotid for any masses that may reveal a parotid malignancy. Examination of the oral cavity for parapharyngeal swellings and vesicular eruptions is also considered essential.
Examine the eye, initially to establish closure of the lid. If the eye is unable to fully close, then urgent ophthalmology referral and provision of eye protection equipment is advised.
Blood tests such as a full blood count, urea and electrolytes, and a C-reactive protein is necessary for all patients admitted due to an infectious cause of facial palsy.
Varicella-zoster virus antibody titers would appear elevated in RHS.
IgG and IgM would become elevated in Lyme disease.
An audiogram should be performed semi-urgently to determine the type of any associated hearing loss and the degree.
Electrophysiological tests are suitable for prognosis; however, they are expensive, time-consuming, and has a short time to be useful (less than three weeks after symptom onset):
CT: If necrotizing otitis externa or a complication of middle ear infection is suspected, or there is a history of head trauma or suspicion of malignancy, a CT of the temporal bones is necessary.
MRI scanning is useful for the detection of intratemporal lesions that may be resulting in compression of the facial nerve and particularly useful for imaging the cerebellopontine angle. MRI scans may also identify the enhancement of the facial nerve around the geniculate ganglion.
Types of surgery for facial paralysis
Transcutaneous Nerve Stimulation Transcutaneous nerve stimulation is an additional new treatment option for those with unilateral facial nerve palsy. The technology uses EMG signals from muscles on the intact side of the face to simultaneously stimulate the corresponding muscles on the side of paresis. The ultimate aim of therapy is to achieve facial symmetry. Early trials have shown positive results in significant domains of facial expression where the affected side is paretic, with some degree of reinnervation.
The most important factor when considering the differential diagnosis of facial nerve palsy is whether the lesion is LMN or UMN.
Due to bilateral cortical innervation of the muscles of the upper face, only LMN lesions will result in complete facial paralysis, although this is not always the case. Consequently, the most clinically useful assessment of UMN vs. LMN facial nerve palsy is raising of the eyebrows which assess frontalis and orbicularis oculi.
Lower motor neuronal lesions are ones such as Bell palsy, Ramsay Hunt syndrome, and others further described in this article. Upper motor neuronal lesions are responsible for causing facial nerve palsy include stroke, multiple sclerosis, subdural hemorrhage, and intracranial neoplasia.
Factors suggestive of a poor prognosis when associated with a facial nerve palsy include:
Complications of facial nerve palsy are numerous and significant. Conservative eye care aims to reduce possible ophthalmic complications associated with a facial nerve palsy that include exposure keratitis and drying of the cornea with potential ulceration.
However, other hyperkinetic complications associated with facial nerve palsy include hemifacial spasm, facial asymmetry, and synkinesis.
Management for these hyperkinetic complications of facial nerve palsy includes facial muscle therapy and botulinum toxin treatment. Facial muscle therapy seeks to attempt to strengthen the weaker half of the facial musculature to compensate for synkinesis. Botulinum toxin, however, aims to paralyze facial muscles and is used in managing both synkinesis and hemifacial spasm.
Patients with facial nerve palsy have a unique set of challenges with which to cope. Patient education is vital to reduce the risk of complications through self-management regimes. These include issues such as dealing with dry eyes and mouth, how to tape an eye shut as to avoid corneal abrasion/ulceration, dealing with eating and drinking, a new development of facial expression, speech, and language adjustments (and development in children) to name a few. Providing patients with relevant guides and educational material on how to tackle these issues can be hugely beneficial to patient wellbeing and outcome. This information can also be beneficial to the patient's families and friends who may wish to learn further how best to help support an individual with facial nerve palsy. Additionally, some patients with facial nerve palsies find charities and support groups helpful to meet like-minded people to share ideas and collaborate on how best to manage the condition.
Anatomy of the Facial Nerve
The course of the facial nerve can roughly divide into three portions - origin, intratemporal, and extratemporal.
The motor nucleus of the facial nerve originates within the lower pons and emerges via the cerebellopontine angle (anterior to the anterior inferior cerebellar artery). Here in its intracranial course, it is joined by the nerves intermedius, which consists of the sensory and autonomic fibers of the facial nerve, which originate from the tractus solitaris and superior salivatory nucleus respectively.
The facial nerve then inserts into the internal acoustic meatus (IAM) to begin its meatal segment. The IAM is in the petrous part of the temporal bone between the posterior cranial fossa and the inner ear.
Within the intracranial and meatal segments, no branches are given off.
At the IAM, the facial nerve runs in the anterosuperior compartment. Important structures within the IAM are:
1. Labyrinthine segment - between the IAM+ the geniculate ganglion/first Genu.
This area forms the narrowest portion of the facial nerve (and consequently vulnerable to compromise). At the level of the geniculate ganglion, the facial nerve undergoes the first of two sharp bends (first genu).
At this genu, the greater petrosal nerve branches off from the main trunk. The greater petrosal nerve provides preganglionic parasympathetic fibers to the pterygopalatine ganglion (also known as the vidian nerve). The pterygopalatine ganglion provides postganglionic parasympathetic fibers to the lacrimal, nasal and palatine glands. Proximal lesions are associated with impaired lacrimation, hyperacusis, and loss of taste on the anterior two-thirds of the tongue.
2. Tympanic segment - between the geniculate ganglion and the second genu.
The facial nerve traverses the bony fallopian canal on the medial aspect of the tympanic cavity before its second sharp bend (genu). Important relations of the facial nerve at this point include:
Anteriorly: Processus cochleariformis (where tensor tympani tendon gets directed to the malleus).
Posteriorly: oval window (inferiorly) and the lateral semi-circular canal (superiorly).
The facial nerve runs between the malleus and incus (running medial to the malleus and lateral to the incus).
3. Mastoid segment - from the second genu to the stylomastoid foramen.
After its second genu, the nerve now runs on the posterior aspect of the tympanic cavity. It runs in front and lateral to the ampulla of the posterior semicircular canal and medial to the tympanic annulus.
Both the nerve to stapedius and chorda tympani leave at this segment. The chorda tympani runs anteriorly across the tympanic cavity to provide preganglionic parasympathetic fibers to the submandibular ganglion, which then provides parasympathetic innervation to the submandibular and sublingual glands.
To summarise the three important branches of the facial nerve given off before the nerve leaving the stylomastoid foramen are (GCS):
Branch/Segment of facial nerve/Target
Greater petrosal nerve/Labyrinthine/Pterygopalatine Ganglion (palatine, nasal and lacrimal glands)
Chorda Tympani/Mastoid/Submandibular Ganglion (submandibular and sublingual glands)
(c) Extratemporal: The nerve travels inferiorly and laterally around the styloid process. Prior to entering the parotid gland, it gives off branches to the three following muscles:
Within the parotid gland, the nerve divides the gland into superficial and deep parts. It lies the most superficial structure traversing the parotid gland. Ordered from superficial to deep, the structures within the parotid gland are:
The facial nerve (superficial) —> Retromandibular vein —> External Carotid Artery —> Auriculotemporal Nerve (deep)
Within the substance of the parotid gland, it divides into two trunks (cervicofacial and temporofacial) and then five main branches which each are responsible for innervation of the muscles of facial expression. The five branches with their target muscle and action are below :
Branch of facial nerve/Primary target muscle/Clinical assessment
Zygomatic/Orbicularis oculi/Close eyes
Buccal/Puff cheeks out
Mandibular/Depressor anguli oris/Show bottom teeth
To summarise, the facial nerve innervates the following muscles:
The most important factor when considering the differential diagnosis of facial nerve palsy is whether the lesion is lower motor neuron or upper motor neuron.
Due to bilateral cortical innervation of the muscles of the upper face (in particular orbicularis oculi and frontalis), only lower motor neuron lesions will result in complete facial paralysis, although this is not always the case. Consequently, the most clinically useful assessment of UMN vs. LMN facial nerve palsy is raising of the eyebrows which assess the frontalis and orbicularis oculi.
Lower motor neuronal lesions are ones such as Bell palsy, Ramsay Hunt syndrome, and others further described in this article. Upper motor neuronal lesions that are responsible for causing facial nerve palsy include stroke, multiple sclerosis, subdural hemorrhage, and intracranial neoplasia.
An extensive interprofessional team approach consisting of family physicians, emergency physicians, ENT surgeons, ophthalmologists, radiologists, neurologists, stroke physicians, and maxillofacial surgeons are required to facilitate timely, accurate evaluation and treatment of facial nerve palsies. Paralysis of the facial nerve can present to a variety of healthcare professionals. Therefore it is the responsibility of staff within the primary care setting and also within the emergency department setting to be familiar with the assessment and treatment of this potentially debilitating condition. Following the decision by the initial clinician reviewing the patient (be this a physician and triage nurse) as to whether the palsy is UMN or LMN in nature, then the appropriate next step is further investigations and referral to relevant specialties. Similarly, nursing staff, particularly with experience working on wards caring for patients with head and neck pathologies, should be able to recognize the symptoms and signs of a developing facial palsy. Should a patient develop a facial palsy (particularly in the context of the postoperative period in for example otological surgery or those admitted with a necrotizing otitis externa), then rapid communication to the physician in charge of the patient's care in addition to the rest of the interprofessional team will enhance outcomes.
If the event the treating clinicians chooses pharmaceutical therapy, it would be prudent to enlist the expertise of a pharmacist to verify all dosing, perform medication reconciliation, and counsel the patient in tandem with nursing on proper administration and what side effects may present.
Finally, in the management of patients with facial nerve palsies, an important role is that of both the physiotherapists and speech and language therapists. This intervention is primarily from a rehabilitation perspective, providing patients with facial exercises and therapy to help ultimately restore function in the long term.
A well balanced interprofessional team that provides an integrated and fully holistic approach in patients with facial nerve palsies is essential in achieving superior outcomes. [Level 5]
|||Coulson SE,O'dwyer NJ,Adams RD,Croxson GR, Expression of emotion and quality of life after facial nerve paralysis. Otology [PubMed PMID: 15547436]|
|||De Diego-Sastre JI,Prim-Espada MP,Fernández-García F, [The epidemiology of Bell's palsy]. Revista de neurologia. 2005 Sep 1-15; [PubMed PMID: 16138286]|
|||Holland NJ,Weiner GM, Recent developments in Bell's palsy. BMJ (Clinical research ed.). 2004 Sep 4; [PubMed PMID: 15345630]|
|||Cannon CR,Jahrsdoerfer RA, Temporal bone fractures. Review of 90 cases. Archives of otolaryngology (Chicago, Ill. : 1960). 1983 May [PubMed PMID: 6847478]|
|||Donnan GA,Fisher M,Macleod M,Davis SM, Stroke. Lancet (London, England). 2008 May 10; [PubMed PMID: 18468545]|
|||Ciorba A,Corazzi V,Conz V,Bianchini C,Aimoni C, Facial nerve paralysis in children. World journal of clinical cases. 2015 Dec 16 [PubMed PMID: 26677445]|
|||Barr JS,Katz KA,Hazen A, Surgical management of facial nerve paralysis in the pediatric population. Journal of pediatric surgery. 2011 Nov [PubMed PMID: 22075352]|
|||Teller DC,Murphy TP, Bilateral facial paralysis: a case presentation and literature review. The Journal of otolaryngology. 1992 Feb [PubMed PMID: 1564749]|
|||Jain V,Deshmukh A,Gollomp S, Bilateral facial paralysis: case presentation and discussion of differential diagnosis. Journal of general internal medicine. 2006 Jul [PubMed PMID: 16808763]|
|||Peitersen E, Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta oto-laryngologica. Supplementum. 2002; [PubMed PMID: 12482166]|
|||Rahman I,Sadiq SA, Ophthalmic management of facial nerve palsy: a review. Survey of ophthalmology. 2007 Mar-Apr; [PubMed PMID: 17355853]|
|||Masterson L,Vallis M,Quinlivan R,Prinsley P, Assessment and management of facial nerve palsy. BMJ (Clinical research ed.). 2015 Sep 16; [PubMed PMID: 26378061]|
|||Reitzen SD,Babb JS,Lalwani AK, Significance and reliability of the House-Brackmann grading system for regional facial nerve function. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 2009 Feb [PubMed PMID: 19201280]|
|||Riordan M, Investigation and treatment of facial paralysis. Archives of disease in childhood. 2001 Apr; [PubMed PMID: 11259220]|
|||Har-El G,McPhee JR, Transcranial magnetic stimulation in acute facial nerve injury. The Laryngoscope. 2000 Jul [PubMed PMID: 10892678]|
|||Williamson IG,Whelan TR, The clinical problem of Bell's palsy: is treatment with steroids effective? The British journal of general practice : the journal of the Royal College of General Practitioners. 1996 Dec; [PubMed PMID: 8995858]|
|||Browning GG, Bell's palsy: a review of three systematic reviews of steroid and anti-viral therapy. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology [PubMed PMID: 20447166]|
|||Uscategui T,Doree C,Chamberlain IJ,Burton MJ, Corticosteroids as adjuvant to antiviral treatment in Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. The Cochrane database of systematic reviews. 2008 Jul 16 [PubMed PMID: 18646170]|
|||Uscategui T,Dorée C,Chamberlain IJ,Burton MJ, Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults. The Cochrane database of systematic reviews. 2008 Oct 8 [PubMed PMID: 18843734]|
|||Antony S, Mosquito and Tick-borne Illnesses in the United States. Guidelines for the Recognition and Empiric Treatment of Zoonotic Diseases in the Wilderness. Infectious disorders drug targets. 2019 [PubMed PMID: 29943705]|
|||McAllister K,Walker D,Donnan PT,Swan I, Surgical interventions for the early management of Bell's palsy. The Cochrane database of systematic reviews. 2013 Oct 16; [PubMed PMID: 24132718]|
|||Humphrey CD,Kriet JD, Nerve repair and cable grafting for facial paralysis. Facial plastic surgery : FPS. 2008 May [PubMed PMID: 18470828]|
|||Mehta RP, Surgical treatment of facial paralysis. Clinical and experimental otorhinolaryngology. 2009 Mar [PubMed PMID: 19434284]|
|||Terzis JK,Konofaos P, Nerve transfers in facial palsy. Facial plastic surgery : FPS. 2008 May [PubMed PMID: 18470829]|
|||Mäkelä E,Venesvirta H,Ilves M,Lylykangas J,Rantanen V,Ylä-Kotola T,Suominen S,Vehkaoja A,Verho J,Lekkala J,Surakka V,Rautiainen M, Facial muscle reanimation by transcutaneous electrical stimulation for peripheral facial nerve palsy. Journal of medical engineering & technology. 2019 Apr [PubMed PMID: 31305190]|
|||Ikeda M,Abiko Y,Kukimoto N,Omori H,Nakazato H,Ikeda K, Clinical factors that influence the prognosis of facial nerve paralysis and the magnitudes of influence. The Laryngoscope. 2005 May; [PubMed PMID: 15867653]|
|||Valls-Solé J, Facial nerve palsy and hemifacial spasm. Handbook of clinical neurology. 2013; [PubMed PMID: 23931790]|
|||Ziahosseini K,Nduka C,Malhotra R, Ophthalmic grading of facial paralysis: need for a closer look. The British journal of ophthalmology. 2015 Sep; [PubMed PMID: 25563764]|
|||Borodic G,Bartley M,Slattery W,Glasscock M,Johnson E,Malazio C,Goodnough M,Acquadro M,McKenna M, Botulinum toxin for aberrant facial nerve regeneration: double-blind, placebo-controlled trial using subjective endpoints. Plastic and reconstructive surgery. 2005 Jul; [PubMed PMID: 15988245]|